The largest database of trusted experimental protocols

Chod pap method

Manufactured by Roche
Sourced in Germany

The CHOD-PAP method is a laboratory technique used for the quantitative determination of cholesterol levels in biological samples. It is a colorimetric assay that relies on the enzymatic conversion of cholesterol by cholesterol oxidase (CHOD) and the subsequent reaction with 4-aminophenazone (PAP) to produce a colored complex, which is measured photometrically. This method provides a reliable and standardized way to measure cholesterol concentrations in clinical and research settings.

Automatically generated - may contain errors

9 protocols using chod pap method

1

Lipid Profile Changes After Exercise

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve-hour fasting venous blood samples were drawn at baseline, week 4 and at two follow up days in week 8. The first follow up sample was collected 43 h (median: range 19–72 h) and the second follow up sample 117 h (70–118 h) after an exercise training. Blood samples were centrifuged at 1300x g for 15 min at 21 °C to collect serum samples that were stored at − 80 °C until analyzed at the end of the study. Serum TC (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), HDL-C (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), and TG concentrations were analyzed with enzymatic methods (GPO-Tinder; Sigma-Aldrich Corp., St. Louis, MO, USA).
+ Open protocol
+ Expand
2

Plasma Lipid and HDL Functionality Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the samples collected at baseline and after 24 h, plasma TC (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), HDL-C (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), and TG concentrations were analyzed enzymatically (GPO-Tinder; Sigma-Aldrich Corp., St. Louis, MO, USA). In these samples, plasma LDL-C concentrations were calculated using the Friedewald equation [22 (link)]. HDL functionality, defined as the capacity of radioactive cholesterol efflux from cultured J774 macrophages, using liquid scintillation counting was determined as described elsewhere [23 (link)]. Markers for inflammation were analyzed in the plasma samples collected at all time points as described [13 (link)].
+ Open protocol
+ Expand
3

Automated Lipid Profile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum total cholesterol (TC) (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), high-density lipoprotein cholesterol (HDL-C) (CHOD-PAP method; Roche Diagnostic, Mannheim, Germany), and triglyceride (TG) concentrations—corrected for glycerol levels—were analyzed enzymatically (GPO-Tinder; Sigma-Aldrich Corp., St. Louis, MO, USA). Serum low-density lipoprotein cholesterol (LDL-C) concentrations were calculated using the Friedewald equation [18 (link)].
+ Open protocol
+ Expand
4

Enzymatic Cholesterol and Triglyceride Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrations of serum total cholesterol (CHOD-PAP method; Roche Diagnostics Systems, Hoffmann-La Roche) and TAG with correction for free glycerol (GPO-Trinder; Sigma Diagnostics) were determined enzymatically in fasting serum samples.
+ Open protocol
+ Expand
5

Circadian Analysis of Metabolic Parameters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats from each group were sacrificed at ZT 2:00, 6:00, 10:00, 14:00, 18:00 and 22:00 h. The liver tissues were immediately frozen in liquid nitrogen and stored in RNAlater (cat. no. AM7020; Ambion; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at −80°C. Blood samples were centrifuged at 6,391 × g for 10 min at 4°C. Samples were sent to the Department of Laboratory Medicine, PUMCH (Beijing, China). The following measurements were performed with a Hitachi Modular P800 analyzer (Hitachi, Ltd., Tokyo, Japan): Serum total cholesterol (TC) (CHOD-PAP method; Roche Diagnostics GmbH, Mannheim, Germany) (18 (link)), serum TGs (GP0-PAP method; Roche Diagnostics GmbH), and HDL-C (Roche HDL-C Plus 2nd generation kit; Roche Diagnostics GmbH). LDL-C was calculated using the Friedewald formula (19 (link)). Albumin was measured using the bromopotassium phenol green method (20 (link)) and serum creatinine was measured using a sarcosine oxidase method (21 (link)). Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activity was assessed with an automatic biochemical analyzer. Furthermore, GLU levels were measured using the hexokinase method (22 (link)).
+ Open protocol
+ Expand
6

Quantification of Carotid Artery Intima-Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four weeks after ligation, mice were sacrificed. The arterial tree was perfused with PBS containing 0.1 mg/ml nitroprusside (Sigma, St Louis, MO) and subsequently with 1% paraformaldehyde via a catheter inserted into the left cardiac ventricle. Right carotid artery cross-sections (4 μm thick) were cut at 100 μm intervals. At each level of 100 μm, a cross-section was stained with Lawson solution and used to determine intima, lumen and total vessel area as well as elastic lamina fragmentation. The relative intimal collagen content, i.e. the percentage of total intima area that stained positive for Sirius red, was determined under a microscope coupled to a computerized morphometry system (Quantimet 570, Leica). Morphometric analyses were performed by a blinded investigator (LB, intra-observer variability was < 10%) using a computerized morphometry system (Quantimet 570, Leica). Serum cholesterol level was determined with the CHOD-PAP method (Roche Diagnostics).
+ Open protocol
+ Expand
7

Fasting Biomarker Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were drawn from the antecubital vein by venipuncture (BL, MT, and FU-A) or from an intravenous catheter (FUeB). Blood in serum separator tubes (Becton, Dickinson and Company, Franklin Lakes, NY, USA) was allowed to clot for at least 60 min at room temperature before samples were centrifuged (15 min at 1500 g at room temperature), distributed in aliquots, snap frozen, and stored at À80 C until analysis at the end of the study. Serum was used for the analysis of C-reactive protein (CRP; immunoturbidimetric assay, Horiba ABX, Montpellier, France), TAG with correction for free glycerol (Trinder; SigmaeAldrich Corp., St. Louis, MO, USA), TC, and high-density lipoprotein (HDL)-cholesterol (CHOD-PAP method; Roche Diagnostics System, Mannheim, Germany), and isoflavone concentrations (i.e., daidzein, genistein, and equol; LC-MS/MS technique by LGC Limited, analyzed at LGC Limited, Fordham, UK) [24] . Serum concentrations of daidzein and genistein were used to measure compliance, while serum equol concentrations were determined to differentiate between equolproducers and non-producers [25] . Finally, serum low-density lipoprotein (LDL)-cholesterol concentrations were calculated using the Friedewald formula [26] .
+ Open protocol
+ Expand
8

Plasma Glucose and Lipid Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma prepared from blood collected in sodium fluoride (NaF) and Na2EDTA (Becton Dickinson, Erembodegem, Belgium) tubes were used for the determination of plasma glucose concentrations (Glucose HK CP, Horiba ABX, Montpellier, France) at all time points. In addition, blood was sampled in serum STT-II advance tubes (Becton Dickinson) for the determination of serum triacylglycerol (TAG; GPO Trinder, Sigma-Aldrich Corp., St. Louis, MO, USA) concentrations with correction for free glycerol at T0, T60, T120, and T180. In addition, serum total (CHOD-PAP method; Roche Diagnostic Systems), high-density lipoprotein cholesterol (HDL-cholesterol; precipitation method (phosphotungstate precipitant); Roche Diagnostics, Mannheim, Germany) and high-sensitivity C-reactive protein (hsCRP; CRP CP, Horiba ABX, Montpellier, France) concentrations at T0 were measured. Fasting serum low-density lipoprotein (LDL)-cholesterol concentrations were calculated using the Friedewald formula [13 (link)]. More details regarding the biochemical analyses can be found in our previous study [12 (link)].
+ Open protocol
+ Expand
9

Blood Sample Collection and Biochemical Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in serum STT-II advance tubes (Becton Dickinson). After a minimum of 30 min clotting time at room temperature, tubes were centrifuged at 1300 g for 10 min at 21°C to obtain serum. In addition, on day 0, blood was collected in sodium fluoride (NaF) tubes (Becton Dickinson). Directly after sampling, these NaF tubes were centrifuged at 1300 g for 10 min at 4 °C to obtain plasma. Subsequently, serum and plasma were portioned into aliquots, frozen in liquid nitrogen, and stored at -80°C until analyses.
Brain-derived neurotrophic factor (BDNF) was measured in serum samples of day 0 and 27 of each period by an enzyme-linked immunosorbent assay (Duo Kit ELISA, R & D Systems, Minneapolis, MN, United States) according to manufacturer's instructions. Fasting TAG (GPO Trinder, Sigma-Aldrich Corp., St. Louis, MO, United States), total cholesterol (CHOD-PAP method; Roche Diagnostic Systems), and HDL cholesterol concentrations (precipitation method; Roche Diagnostics, Mannheim, Germany) were measured in serum samples at baseline. LDL cholesterol was calculated using the Friedewald equation [Citation15] . Fasting glucose concentrations (Glucose HK CP, Horiba ABX, Montpellier, France) were measured in NaF plasma samples at baseline.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!